Allergan, Argentum settle patent dispute over eye drug Restasis

U.S. generic drug company Argentum Pharmaceuticals LLC said on Tuesday it had reached an agreement with Allergan Plc that settles a patent dispute over the generic version of Allergan’s eye drug, Restasis.

The agreement gives Argentum the right to sell the copycat version of Restasis before the patents covering the drug expire, Argentum said. It did not disclose when it would launch the generic product.

Restasis, which was approved by the U.S. Food and Drug Administration in 2002, is used to treat dry eye.

(Reporting by Divya Grover in Bengaluru; Editing by Sai Sachin Ravikumar)

Read More at Reuters

Get more stuff like this
in your inbox

Subscribe to our mailing list and get interesting stuff and updates to your email inbox.

Thank you for subscribing.

Something went wrong.

5 Healthy Ways This Fitness Star Is Prepping for Her Wedding
4 Healthy Reasons to Eat Avocados
The Salad Trend You Didn’t Know You Needed
Got 30 Minutes? The Ultimate HIIT Jump Rope Workout
5 Healthy Ways This Fitness Star Is Prepping for Her Wedding
4 Ideas for Using Herbs You Probably Haven’t Thought Of
Bobbi Brown’s Top 10 Superfoods for Beauty and the Fun Way She Eats Them
Lena Dunham’s Trainer Tracy Anderson Says She Wanted to ‘Feel Better’ and Not Make Her Body ‘Look Different’
The Easy Frozen Yogurt Dessert You’ll Be Eating All Summer Long
A Food-Lover’s Mother’s Day Gift Guide
4 Foolproof Tips to Make Healthy Veggie Chips at Home
4 Healthy Reasons to Eat Avocados
No Preview
WHO says India reports cases of Zika virus
Two Scientists, Two Different Approaches To Saving Bees From Poison Dust
How A Gene Editing Tool Went From Labs To A Middle-School Classroom
Sensory and diet therapies for autism lack strong evidence